Wegovy

By: Quiet. Please
Listen for free

  • Summary

  • This series on Wegovy provides an in-depth look into the popular weight loss medication. The first episode introduces Wegovy, explaining its mechanism, clinical trials, and patient eligibility. The second episode delves into the benefits and potential risks, including effectiveness, side effects, and comparisons with other treatments. The final episode covers practical considerations such as usage, lifestyle integration, cost, and future developments. This series offers a comprehensive understanding for anyone considering Wegovy as a weight management solution.
    2024 Quiet. Please
    Show more Show less
Hygiene & Healthy Living Physical Illness & Disease
Show more Show less
Episodes
  • Wegovy Weight Loss Drug Faces Legal Challenges, Expanded Options, and Promising Clinical Trials in 2025

    Wegovy Weight Loss Drug Faces Legal Challenges, Expanded Options, and Promising Clinical Trials in 2025
    Apr 21 2025
    # Wegovy in the Spotlight: Latest Developments and Controversies

    Explore the rapidly evolving landscape of Novo Nordisk's groundbreaking weight loss medication in this comprehensive episode. Host Alexandra Reeves breaks down the latest Wegovy developments, including FDA applications for a new oral formulation, expanding legal challenges related to side effects, and significant price reductions making the treatment more accessible to patients.

    Discover eye-opening clinical trial results showing enhanced effectiveness with higher dosages, where patients lost nearly 19% of their body weight, and learn how Wegovy's tremendous market success ($9.4 billion in sales) is reshaping pharmaceutical priorities. The episode also examines resolved supply issues, intensifying competition from Eli Lilly's Zepbound, and the broader societal implications of these GLP-1 medications beyond obesity treatment.

    Whether you're a current user, healthcare professional, or simply interested in the intersection of medical innovation and healthcare economics, this episode offers essential insights into one of today's most transformative medications and the controversies surrounding its use.
    Show more Show less
    5 mins
  • Wegovy Weight Loss Drug Sparks Legal Battles, Pricing Debates, and Medical Innovation Amid Pharmaceutical Breakthrough

    Wegovy Weight Loss Drug Sparks Legal Battles, Pricing Debates, and Medical Innovation Amid Pharmaceutical Breakthrough
    Apr 19 2025
    # Wegovy: The Weight Loss Drug Reshaping Healthcare, Economics, and Society

    In this insightful episode of Alexandra Reeves' podcast, dive into the multifaceted story of Wegovy, the revolutionary weight loss medication that's transcended medical discussions to impact economics, legal systems, and social conversations nationwide.

    Alexandra unpacks the latest developments including the resolution of supply shortages, significant price reductions, and mounting legal challenges as patients report severe side effects. Learn how Novo Nordisk's pricing strategy has evolved amid growing competition, with retail pharmacies now offering Wegovy for under $500 monthly compared to the $1,349 list price.

    The episode explores the clinical advancements showing higher doses can produce up to 19% body weight loss, the FDA's crackdown on compounded versions, and the surprising potential applications for addiction treatment. Beyond the science, Alexandra examines how this pharmaceutical phenomenon reflects broader themes in modern healthcare, from corporate profits to patient access inequities.

    Perfect for healthcare professionals, policy enthusiasts, or anyone following the obesity treatment revolution, this comprehensive analysis provides crucial context for understanding how Wegovy is reshaping both waistlines and our healthcare landscape.
    Show more Show less
    7 mins
  • Wegovy Breakthrough: FDA Resolves Shortage, Reveals New Insights on Weight Loss and Medical Innovation

    Wegovy Breakthrough: FDA Resolves Shortage, Reveals New Insights on Weight Loss and Medical Innovation
    Apr 14 2025
    # Wegovy Breakthrough: FDA Shortage Resolution & New Developments | Quiet Please Podcast

    Explore the latest developments in the Wegovy weight loss revolution with host Alexandra Reeves. This episode unpacks the FDA's recent resolution of Wegovy shortages, making this groundbreaking obesity medication more accessible to patients nationwide. Learn about Novo Nordisk's extended savings program reducing costs to $499/month for eligible uninsured patients—a significant drop from the $1,349 list price.

    We dive into the scientific advancements with the STEP UP study revealing a high-dose Wegovy option achieving 20.7% weight loss, surpassing the standard dose. The episode also examines the growing legal challenges with over 1,500 cases now in multi-district litigation regarding potential side effects.

    From its economic impact boosting Denmark's economy to its cultural significance in Hollywood and beyond, discover how Wegovy is reshaping our understanding of obesity treatment, healthcare accessibility, and pharmaceutical innovation. Subscribe to Quiet Please for ongoing coverage of this medical breakthrough that generated $9.4 billion in revenue last year alone.
    Show more Show less
    4 mins
adbl_web_global_use_to_activate_webcro768_stickypopup

What listeners say about Wegovy

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available